Oncotarget

Corrections:

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development

PDF  |  How to cite

Oncotarget. 2019; 10:5670-5670. https://doi.org/10.18632/oncotarget.27218

Metrics: PDF 431 views  |   ?  

Laura Molina1,2,*, Hong Yang3,*, Adeola O. Adebayo Michael4, Michael Oertel1,5, Aaron Bell1, Sucha Singh1, Xin Chen6, Junyan Tao1 and Satdarshan P. Monga1,5,7

1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
3 Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
4 Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
5 Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA
6 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, USA
7 Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
* These authors have contributed equally to this work

Published: September 24, 2019

This article has been corrected: The correct author information is given below:

Satdarshan P. Monga

Original article: Oncotarget. 2019; 10:1475-1490. DOI: https://doi.org/10.18632/oncotarget.26668.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27218